A study to assess safety and acceptability ofa treatment in patients with ALS
A Phase II pilot safety and tolerability study of ILB in patients with Motor Neurone Disease (MND)/Amyotrophic Lateral Sclerosis (ALS) - The ALS Study A Phase II pilot safety and tolerability study ofILB in patients with Motor Neurone Disease (MND)/Am ...
Motor Neurone Disease (MND)/Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10002026;Term: Amyotrophic lateral sclerosis;System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] Motor Neurone Disease (MND)/Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Class ...
Product Name: ILB: 100mg/ml solution for injection and infusion INN or Proposed INN: DextranSodiumSulfurSalt5,Mw5kDa.atypeofLowMolecularWeightDextranSulfate(LMW-DS) Other descriptive name: ILB Product Name: ILB: 100mg/ml solution for injection and infusion INN or Proposed INN: DextranSodiumS ...